• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION SPACEOAR VUE SYSTEM; ABSORBABLE PERIRECTAL SPACER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION SPACEOAR VUE SYSTEM; ABSORBABLE PERIRECTAL SPACER Back to Search Results
Model Number SV-2101
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Arrhythmia (1721); Cardiac Arrest (1762); Hypersensitivity/Allergic reaction (1907); Low Blood Pressure/ Hypotension (1914); Hypovolemic Shock (1917); Rash (2033); Diminished Pulse Pressure (2606)
Event Date 09/27/2022
Event Type  Injury  
Event Description
It was reported to boston scientific corporation that a spaceoar vue device was implanted during a spaceoar vue placement procedure under general anesthesia, on (b)(6) 2022.The spaceoar vue placement procedure was performed without complications.At the end of the procedure when the anesthesiologist moved to intubate the patient, the patient's pressure dropped to 42/29, and he went into ventricular tachycardia.At that point, the patient did not have a pulse at all.Cardiopulmonary resuscitation (cpr) was required, they gave him epinephrine and chest compressions for about five or ten minutes and eventually the patient came back into sinus rhythm.The interventional cardiologist performed an urgent echography, the myocardium was fine, and the ejection fraction (ef) was fifty percent.Tha patient was noted to have a full-blown maculopapular rash from the neck all the way down to the groin.In the physician assessment, the patient experienced an anaphylactic reaction.During the case the patient was treated with ancef, xylocaine (4cc) to the perineum, and anesthesia maintained him on propofol and versed.The physician used betadine (10cc) to prep the perineal area.The patient was reported to be fully recovered in the intensive care unit (icu).The patient's blood pressure was back to normal.The patient's rash has totally disappeared and is gone.Boston scientific has been unable to obtain more details despite of the good faith efforts.
 
Manufacturer Narrative
The complainant was unable to provide the suspect device lot number; therefore, the lot expiration and device manufacture dates are unknown.(b)(4).
 
Manufacturer Narrative
Corrected fields: block h6 (patient codes): ar codes 9139: hypotension and 9235: pulse, loss of, were added.Ar code 9254: shock, hypovolemic was removed.Block d4, h4: the complainant was unable to provide the suspect device lot number; therefore, the lot expiration and device manufacture dates are unknown.Block h6: patient code e1714 captures the reportable event of rash.Patient code e0402 captures the reportable event of hypersensitivity/allergic reaction.Patient code e1714 captures the reportable event of arrhythmia.Patient code e0609 captures the reportable event of pulse, loss of.Patient code e1714 captures the reportable event of cardiac arrest.Patient code e2321 captures the reportable event of hypotension.
 
Event Description
It was reported to boston scientific corporation that a spaceoar vue device was implanted during a spaceoar vue placement procedure under general anesthesia, on (b)(6) 2022.The spaceoar vue placement procedure was performed without complications.At the end of the procedure when the anesthesiologist moved to intubate the patient, the patient's pressure dropped to 42/29, and he went into ventricular tachycardia.At that point, the patient did not have a pulse at all.Cardiopulmonary resuscitation (cpr) was required, they gave him epinephrine and chest compressions for about five or ten minutes and eventually the patient came back into sinus rhythm.The interventional cardiologist performed an urgent echography, the myocardium was fine, and the ejection fraction (ef) was fifty percent.The patient was noted to have a full-blown maculopapular rash from the neck all the way down to the groin.In the physician assessment, the patient experienced an anaphylactic reaction.During the case the patient was treated with ancef, xylocaine (4cc) to the perineum, and anesthesia maintained him on propofol and versed.The physician used betadine (10cc) to prep the perineal area.The patient was reported to be fully recovered in the intensive care unit (icu).The patient was intubated.The patient's blood pressure was back to normal.The patient was responding and gave a thumbs up.The patient's rash had totally disappeared and was gone.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SPACEOAR VUE SYSTEM
Type of Device
ABSORBABLE PERIRECTAL SPACER
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
BOSTON SCIENTIFIC CORK LIMITED
500 commander shea boulevard
quincy MA 02171
Manufacturer Contact
carole morley
300 boston scientific way
marlborough, MA 01752
5086834015
MDR Report Key15643369
MDR Text Key302163803
Report Number3005099803-2022-06169
Device Sequence Number1
Product Code OVB
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K182971
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 11/18/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberSV-2101
Device Catalogue NumberSV-2101
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 09/27/2022
Initial Date FDA Received10/20/2022
Supplement Dates Manufacturer Received10/26/2022
Supplement Dates FDA Received11/19/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention; Hospitalization;
Patient Age65 YR
Patient SexMale
-
-